 |
Articles: Nuclear Medicine |
Prior Articles
186Re-maSGS-ZHER2:342, a potential Affibody conjugate for systemic therapy of HER2-expressing tumours
European Journal of Nuclear Medicine & Molecular Imaging, 09/24/09
Prediction of Progression-Free Survival in Patients With Multiple Myeloma Following Anthracycline-Based Chemotherapy Based on Dynamic FDG-PET
Clinical Nuclear Medicine, 09/24/09 F-18 FDG PET/CT Findings in a Patient With Bilateral Orbital and Gastric Mucosa-Associated Lymphoid Tissue Lymphomas
Clinical Nuclear Medicine, 09/24/09 Unexpected Accumulation of F-18 FDG in the Urinary Bladder After Bladder Irrigation and Retrograde Filling With Sterile Saline: A Possible Pitfall in PET Examination
Clinical Nuclear Medicine, 09/24/09 A Rare Presentation of Metastatic Renal Clear Cell Carcinoma to the Tongue Seen on FDG PET
Clinical Nuclear Medicine, 09/24/09 18F-FDG PET/CT Identifies Patients at Risk for Future Vascular Events in an Otherwise Asymptomatic Cohort with Neoplastic Disease
The Journal of Nuclear Medicine, 09/24/09 Melanin-Targeted Preclinical PET of Melanoma Metastasis
The Journal of Nuclear Medicine, 09/24/09
Exclusive Author Commentary 131I-6 beta-Iodomethyl-19-Norcholesterol SPECT/CT for Primary Aldosteronism Patients with Inconclusive Adrenal Venous Sampling and CT Results
The Journal of Nuclear Medicine, 09/24/09 Salivary Gland Side Effects Commonly Develop Several Weeks After Initial Radioactive Iodine Ablation
The Journal of Nuclear Medicine, 09/24/09 A Biomathematical Modeling Approach to Central Nervous System Radioligand Discovery and Development
The Journal of Nuclear Medicine, 09/24/09 Adolescent Idiopathic Scoliosis May Not Be Associated with Brain Abnormalities
Acta Radiologica, 09/23/09 A dose-effect correlation for radioiodine ablation in differentiated thyroid cancer
European Journal of Nuclear Medicine & Molecular Imaging, 09/23/09 Intraoperative avidination for radionuclide treatment as a radiotherapy boost in breast cancer: results of a phase II study with 90Y-labeled biotin
European Journal of Nuclear Medicine & Molecular Imaging, 09/23/09 Repeatability of 18F-FDG PET in a Multicenter Phase I Study of Patients with Advanced Gastrointestinal Malignancies
The Journal of Nuclear Medicine, 09/23/09 Functional Images Reflect Aggressiveness of Endometrial Carcinoma: Estrogen Receptor Expression Combined with 18F-FDG PET
The Journal of Nuclear Medicine, 09/23/09 Predictive factors of [11C]choline PET/CT in patients with biochemical failure after radical prostatectomy
European Journal of Nuclear Medicine & Molecular Imaging, 09/23/09 Recombinant human TSH and ablation of post-surgical thyroid remnants in differentiated thyroid cancer: the effect of pre-treatment with furosemide and furosemide plus lithium
European Journal of Nuclear Medicine & Molecular Imaging, 09/23/09 Radiolabeled Humanized Anti-CD3 Monoclonal Antibody Visilizumab for Imaging Human T-Lymphocytes
The Journal of Nuclear Medicine, 09/23/09 2-18F-Fluoropropionic Acid as a PET Imaging Agent for Prostate Cancer
The Journal of Nuclear Medicine, 09/22/09 Observer Variation in Interpreting 18F-FDG PET/CT Findings for Lymphoma Staging
The Journal of Nuclear Medicine, 09/22/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Clinical Radiology, American Journal of Roengenology, Academic Radiology
more...
|
250 Available Pages
|
|
